Sort
82,697 grants matching “vaccine development”
Targeting CD4 T follicular helper cells for enhancing HIV vaccine induced humoral immunity
$773,942Swaminathan Smita Iyer · University Of California At Davis · R56 · FY2021 · AI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$773,933Stephanie Jost · Duke University · R01 · FY2023 · AI
Preclinical development of human CMV vaccines
$773,901Michael A McVoy · Virginia Commonwealth University · R01 · FY2011 · AI
Neonatal Immunity to novel TF SHIVs
$773,898Wilton B Williams · Duke University · R01 · FY2018 · AI
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection
$773,874Megan A O'Connor · University Of Washington · R01 · FY2025 · HL
NIDA Clinical Trials Network: Greater New York Node
$773,828John P Rotrosen · New York University School Of Medicine · UG1 · FY2018 · DA
Macaque Models of AIDS-Related Tuberculosis and T Cell
$773,825Zheng W Chen · University Of Illinois At Chicago · R01 · FY2007 · HL
mRNA alternative polyadenylation in B cell development
$773,817Yongsheng Shi · University Of California-Irvine · R01 · FY2024 · AI
Mechanisms and means to improve HIV bnAb activity in vivo
$773,741Margaret E Ackerman · Dartmouth College · R01 · FY2024 · AI
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
$773,738Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2018 · AI
Using Lipids for Vaccination
$773,720Luc Teyton · Scripps Research Institute, The · U01 · FY2010 · AI
Mechanisms of Protection of Universal Therapeutic Antibodies to Influenza A
$773,720Silke Paust · Scripps Research Institute, The · R01 · FY2021 · AI
Recurrence of Cholera in Haiti: Exploration of Contributing Factors and Intervention Strategies
$773,680John Glenn Morris · University Of Florida · R01 · FY2024 · AI
Evolutionary multispecies transcriptomics to reveal genes that govern fungal spore germination and pathogenesis
$773,611Jeffrey Peter Townsend · Yale University · R01 · FY2021 · AI
Does repeated influenza vaccination constrain influenza immune responses and protection?
$773,603Sheena G Sullivan · University Of Melbourne · R01 · FY2019 · AI
Phase 1 Trial of Na-APR-1 and Na-GST-1 Hookworm Vaccines in Brazilian Adults
$773,590David Joseph Diemert · George Washington University · U01 · FY2016 · AI
Novel delivery platform and antigen design for an effective COVID-19 vaccine
$773,534Suresh K Mittal · Purdue University · R01 · FY2021 · AI
Signal Transduction Events and the Regulation of Cell Growth
$773,516Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2013 · CA
Clinical Core
$773,468Cornelia L Dekker · Stanford University · U19 · FY2011 · AI
Administrative Core
$773,455Dennis L. Kasper · Harvard Medical School · U54 · FY2012 · AI
Cellular and molecular programming of lung resident T cell memory
$773,425Jacob E Kohlmeier · Emory University · R35 · FY2025 · HL
Development of New Bivalent Cross-Protective Arenaviral Vaccines
$773,368Igor S. Lukashevich · University Of Louisville · R01 · FY2013 · AI
Small Molecule Protease Inhibitors against MERS-CoV and Coronaviruses of Pandemic Potential
$773,323Kyeong-Ok Chang · Kansas State University · R01 · FY2024 · AI
Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies
$773,296William Robert Jacobs · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Novel DNA Repair Inhibitors for Cancer Therapy
$773,292Peter M Glazer · Yale University · R35 · FY2017 · CA